Stocks · Healthcare · Medical - Instruments & Supplies
KORU Medical Systems, Inc. KRMD
$2.96 -1.99% Close, Oct 2, 2026 · NASDAQ · Market cap $136.0M
Weak trend
Next earnings report: Nov 11, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -3.7% from -13.2% a year earlier.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- The stock is 55% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 31%
- Revenue growth, 3-year CAGRTop 42%
- Revenue growth accelerationBottom 43%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 40%
- Gross marginBottom 47%
- Operating marginTop 46%
- Accruals (lower is better)Top 30%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 33%
- Free-cash-flow yieldTop 35%
- EBITDA / enterprise valueTop 40%
- Sales / enterprise valueTop 38%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 27%
- 6-month returnBottom 15%
- 1-year return vs S&P 500Bottom 27%
- Distance from 52-week highBottom 22%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 11%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyTop 45%
- Upside to consensus price targetTop 37%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 28%
- Maximum drawdown, 3 yearsTop 32%
- Beta vs S&P 500 (lower is better)Top 45%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 23.3% | 22.4% | ↓ |
| Gross margin | 63.2% | 62.0% | ↓ |
| Operating margin | -13.2% | -3.7% | ↑ |
| FCF margin | -6.0% | 0.6% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 22.4% | 23.3% | ↓ | Top 31% |
| Gross margin | 62.0% | 63.2% | ↓ | Bottom 47% |
| Operating margin | -3.7% | -13.2% | ↑ | Top 46% |
| Net margin | -4.0% | -12.3% | ↑ | — |
| Free-cash-flow margin | 0.6% | -6.0% | ↑ | — |
| Return on invested capital | -7.7% | — | Top 40% | |
| Revenue growth, 3-year CAGR | 13.8% | — | Top 42% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -11.5%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 4.7%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -2.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.14%
- Shareholder yield
- -0.14%
- Share count change, 1 year
- +7.2%
- Share count change, 3-year CAGR
- +2.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +59.7%
- Average 2-day reaction, last 8
- +0.6%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $6.00
- Target vs current price
- +102.7%
- Analysts with a rating
- 5
- Share rating Buy or Strong Buy
- 80%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +155.6% | -2.6% | -18.6% | -22.2% | — |
| May 6, 2026 | +0.0% | -1.7% | -2.0% | -3.9% | +0.7% |
| Mar 12, 2026 | +50.0% | -4.4% | -3.5% | -3.1% | -12.9% |
| Nov 12, 2025 | +33.3% | +1.3% | +19.8% | +57.9% | +28.2% |
| Aug 6, 2025 | +133.3% | -0.6% | +26.5% | +23.2% | +20.4% |
| May 7, 2025 | -50.0% | -0.7% | +17.2% | +2.9% | +27.0% |
| Mar 12, 2025 | +0.0% | +5.5% | -6.8% | -33.8% | -6.1% |
| Nov 13, 2024 | -21.1% | +7.7% | +11.4% | +30.3% | +56.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | $0.01 | -$0.02 | +155.6% | $12.0M |
| May 6, 2026 | -$0.02 | -$0.02 | +0.0% | $11.8M |
| Mar 12, 2026 | -$0.01 | -$0.02 | +50.0% | $10.9M |
| Nov 12, 2025 | -$0.02 | -$0.03 | +33.3% | $10.4M |
| Aug 6, 2025 | $0.01 | -$0.03 | +133.3% | $10.2M |
| May 7, 2025 | -$0.03 | -$0.02 | -50.0% | $9.6M |
| Mar 12, 2025 | -$0.03 | -$0.03 | +0.0% | $8.8M |
| Nov 13, 2024 | -$0.03 | -$0.02 | -21.1% | $8.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 2.90× | — | — | Top 38% |
| Free-cash-flow yield | 0.19% | — | — | Top 35% |
| Earnings yield | -1.34% | — | — | Top 33% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -11.5%
- 200-day average slope (20 days)
- -4.9%
- Distance from 50-day average
- -12.7%
- Distance from 200-day average
- -31.1%
- RSI (14)
- 32.1
- Relative volume
- 0.98×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 44.4%
- Volatility vs own 5-year history
- 12th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.01
- Correlation with S&P 500
- 0.30
- Current drawdown from 1-year high
- -54.6%
- Maximum drawdown, 3 years
- -58.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Oct 9, 2020 | Jun 13, 2022 | -73.5% | 421 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $136.0M
- EPS, diluted (TTM)
- -$0.04
- Revenue (TTM)
- $45.1M
- 52-week range
- $2.86 – $6.61
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $23.5M | $27.9M | $28.5M | $33.6M | $41.1M |
| Gross profit | $13.8M | $15.4M | $16.7M | $21.3M | $25.6M |
| Operating income | -$7.0M | -$10.8M | -$10.3M | -$6.4M | -$3.0M |
| Net income | -$4.6M | -$8.7M | -$13.7M | -$6.1M | -$2.6M |
| EPS (diluted) | -$0.10 | -$0.19 | -$0.30 | -$0.13 | -$0.06 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.2M | $8.8M | $9.6M | $10.2M | $10.4M | $10.9M | $11.8M | $12.0M |
| Net income | -$1.6M | -$1.6M | -$1.2M | -$206,867 | -$777,966 | -$486,856 | -$807,078 | $252,449 |
| EPS (diluted) | -$0.03 | -$0.03 | -$0.03 | -$0.00 | -$0.02 | -$0.01 | -$0.02 | $0.01 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$4.3M | -$5.4M | -$4.9M | -$319,718 | $462,405 |
| Capital expenditure | -$375,234 | -$2.8M | -$814,597 | -$1.3M | -$932,517 |
| Free cash flow | -$4.7M | -$8.2M | -$5.7M | -$1.6M | -$470,112 |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $2.2M | $406,623 | $0 | -$97,379 | $186,165 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $8.3M
- Total assets
- $28.0M
- Total liabilities
- $9.9M
- Total debt
- $3.2M
- Net debt
- -$5.0M
- Shareholders’ equity
- $18.1M
As of Jun 30, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 984,588
- Days to cover
- 5.78
- Change vs previous report
- +11.3%
FINRA short interest, settlement date Sep 15, 2026.